Saxagliptin added to a submaximal dose of sulphonylurea improves glycaemic control compared with uptitration of sulphonylurea in patients with type 2 diabetes: a randomised controlled trial.

Source:http://linkedlifedata.com/resource/pubmed/id/19614786

Download in:

View as

General Info

PMID
19614786